145 related articles for article (PubMed ID: 3114516)
1. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
Kageshita T; Ono T; Arao T; Tomita Y
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
[No Abstract] [Full Text] [Related]
2. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
[No Abstract] [Full Text] [Related]
3. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
4. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
Perrot H; Ortonne JP; Schmitt D
Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
[TBL] [Abstract][Full Text] [Related]
5. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
6. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
Tomita Y; Hearing VJ
Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
[TBL] [Abstract][Full Text] [Related]
7. New methodological approach for the rapid and sensitive detection of melanocytes and melanocytic tumours. The DOPA-GA method.
Ichikawa A; Takagi H; Suda K; Yao T
Dermatology; 2009; 219(3):195-201. PubMed ID: 19684380
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase activity in serum from patients with malignant melanoma.
Agrup P; Carstam R; Wittbjer A; Rorsman H; Rosengren E
Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
[TBL] [Abstract][Full Text] [Related]
9. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium.
Dryja TP; O'Neil-Dryja M; Pawelek JM; Albert DM
Invest Ophthalmol Vis Sci; 1978 Jun; 17(6):511-4. PubMed ID: 96039
[TBL] [Abstract][Full Text] [Related]
11. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
Yamamoto H; Takeuchi T
J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
[TBL] [Abstract][Full Text] [Related]
12. Histochemical quantification of dopa-oxidase (tyrosinase) activity in epidermal melanocytes.
Sasai Y; Kumano S; Takahashi M; Nakano H
Histochemistry; 1978 Apr; 55(3):235-43. PubMed ID: 417051
[TBL] [Abstract][Full Text] [Related]
13. [Mouse model of tyrosinase positive type oculocutaneous albinism (chinchilla mouse, Cch/Cch) : tyrosinase activity and ultrastructure of hair bulb melanocyte (author's transl)].
Hori Y; Shichiro M; Mizoguchi M
Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):987-94. PubMed ID: 6780712
[No Abstract] [Full Text] [Related]
14. [The effect of dinitrophenylation on the tyrosinase activity of extracts from human melanomas].
Schwartze G
Dermatol Monatsschr; 1986; 172(8):498-500. PubMed ID: 3095156
[No Abstract] [Full Text] [Related]
15. [Malignant melanoma--a PO-cell tumor? (author's transl)].
Schmidt H; Stintz AR
Arch Geschwulstforsch; 1975; 45(2):146-52. PubMed ID: 812451
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Spectrophotometry measurement of the activity of mushroom and potato tyrosinase].
Schmidt H
Dermatol Monatsschr; 1990; 176(12):757-61. PubMed ID: 2128830
[TBL] [Abstract][Full Text] [Related]
17. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
[No Abstract] [Full Text] [Related]
18. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
Imokawa G; Mishima Y
Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
[TBL] [Abstract][Full Text] [Related]
19. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
Mojamdar M; Imokawa G; Mishima Y
J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody MAT-1 against human tyrosinase can detect melanogenic cells on formalin-fixed paraffin-embedded sections.
Sato N; Suzuki S; Takimoto H; Masui S; Shibata K; Nakano H; Tomita Y
Pigment Cell Res; 1996 Apr; 9(2):72-6. PubMed ID: 8857669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
